Arteris Inc. raises FY26 sales guidance to $95-98M range

Arteris Inc. raised its FY2026 revenue guidance to $95.0 million to $98.0 million, up from $91.0 million to $95.0 million previously. The new range is above the $94.578 million analyst consensus estimate, reflecting stronger-than-expected demand for its NoC interconnects and design automation tools, according to the company.

Original reporting
Published Aug 7, 2026, 2:21 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 7, 2026, 4:41 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Arteris Inc. raises FY26 sales guidance to $95-98M range — source image
Decision brief

The 30-second read

Med
01

Why it matters

The company’s FY2026 revenue guidance is upgraded, implying stronger demand and/or better-than-expected initial license fees and royalty accruals.

02

Market read

A guidance raise that clears consensus can drive repricing of FY26 expectations and near-term momentum in ARTE.

03

What to watch

Traders may want to verify whether the guidance raise is driven by one-time license fees versus recurring royalties, and whether backlog/order inflows are sustainable into FY27.

Relevance 8/10Novelty 8/10Timing: pre-market today (guidance update published 2026-08-07)

Background

Arteris provides semiconductor intellectual property and software solutions, with revenue visibility often tied to licensing and volume-based royalties.

Market effects

A stronger NoC interconnect and design automation adoption narrative can modestly improve sentiment across semiconductor IP and EDA-adjacent names.

None indicated.

None indicated beyond semiconductor IP demand read-through.

Counterpoint

The guidance range is still a forecast, and the article does not quantify margin, cash flow, or customer concentration risk that could limit upside.

Key entities

  • Arteris Inc.

    Semiconductor IP and software provider that raised FY2026 sales guidance to $95.0M-$98.0M.

Related articles

$AIPHighAI 9/10

Arteris, Inc. (AIP): Results of Operations and Financial Condition

Arteris, Inc. (AIP) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 exhibit991q2fy268-k.htm EX-99.1 Document Arteris Announces Financial Results for the Second Quarter and Estimated Third Quarter and Updated Full Year 2026 Guidance CAMPBELL, Calif. - August 6, 2026 - Arteris, Inc. (Nasdaq: AIP), a leading provider of semiconductor techn

$KDMed

Kyndryl Q1 Earnings Call Highlights

Kyndryl (NYSE:KD) Q1 call said demand is rising for AI deployment, hybrid modernization, cybersecurity and data-residency. It reported 40 deals worth over $50M in 12 months, with 10 in Q1, and Kyndryl Consult signings up 50%. IBM relationship changes are expected to weigh on constant-currency revenue through FY2027. FCF was -$401M; cash $2.1B. Outlook FY2027 reaffirmed.

$KAIMedAI 8/10

Kadant Q2 Earnings Call Highlights

Kadant (NYSE:KAI) reported Q2 equipment backlog of $182 million and said aftermarket demand stayed at record or near-record levels. Flow Control revenue rose 5% to $100 million; Industrial Processing revenue rose to a record $144 million; Material Handling bookings were $73 million. Q2 gross margin fell to 43.8%. Kadant raised FY revenue guidance to $1.19-$1.21B and adjusted EPS to $12.43-$12.68.

$KRPMed

Kimbell Royalty Q2 Earnings Call Highlights

Kimbell Royalty (NYSE:KRP) reported record Q2 adjusted EBITDA of $84.9 million, with cash G&A of $5.9 million ($2.50 per BOE). It declared a $0.47 per common unit cash distribution, up 15% QoQ, and said 47% may be return of capital. The borrowing base rose to $660 million; debt was $478.7 million. Rig activity and production varied by basin.

$KMPRMed

Kemper Q2 Earnings Call Highlights

Kemper (NYSE:KMPR) reported Q2 results and discussed credit-loss allowances tied to surplus notes in its reciprocal exchange, including a $21 million pre-tax charge on $36 million of notes. Holding-company liquidity was $766 million and debt-to-capital rose to 28.3%. Personal auto normalized combined ratio was 102% and commercial 93.7%, with California rate actions and restructuring savings over $80 million run-rate.